[go: up one dir, main page]

AU2001296731A1 - Antisense modulation of bcas1 expression - Google Patents

Antisense modulation of bcas1 expression

Info

Publication number
AU2001296731A1
AU2001296731A1 AU2001296731A AU9673101A AU2001296731A1 AU 2001296731 A1 AU2001296731 A1 AU 2001296731A1 AU 2001296731 A AU2001296731 A AU 2001296731A AU 9673101 A AU9673101 A AU 9673101A AU 2001296731 A1 AU2001296731 A1 AU 2001296731A1
Authority
AU
Australia
Prior art keywords
bcas1
expression
antisense modulation
antisense
modulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001296731A
Inventor
Lex M Cowsert
Susan M Freier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ionis Pharmaceuticals Inc
Original Assignee
Isis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isis Pharmaceuticals Inc filed Critical Isis Pharmaceuticals Inc
Publication of AU2001296731A1 publication Critical patent/AU2001296731A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001296731A 2000-10-11 2001-10-09 Antisense modulation of bcas1 expression Abandoned AU2001296731A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09689255 2000-10-11
US09/689,255 US6395544B1 (en) 2000-10-11 2000-10-11 Antisense modulation of BCAS1 expression
PCT/US2001/031484 WO2002031136A1 (en) 2000-10-11 2001-10-09 Antisense modulation of bcas1 expression

Publications (1)

Publication Number Publication Date
AU2001296731A1 true AU2001296731A1 (en) 2002-04-22

Family

ID=24767669

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001296731A Abandoned AU2001296731A1 (en) 2000-10-11 2001-10-09 Antisense modulation of bcas1 expression

Country Status (3)

Country Link
US (1) US6395544B1 (en)
AU (1) AU2001296731A1 (en)
WO (1) WO2002031136A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050204388A1 (en) * 1998-06-11 2005-09-15 Knudson Edward B. Series reminders and series recording from an interactive television program guide
AU2003295617A1 (en) * 2002-11-18 2004-06-15 Panomics, Inc. Rnai-based sensors, caged interfering rnas, and methods of use thereof
US7598227B2 (en) 2003-04-16 2009-10-06 Isis Pharmaceuticals Inc. Modulation of apolipoprotein C-III expression
CN103333885A (en) 2003-06-23 2013-10-02 先锋高级育种国际公司 Engineering single-gene-controlled staygreen potential into plants
EP1954834B1 (en) 2005-11-29 2012-08-08 Cambridge Enterprise Limited Markers for breast cancer
EP2272969A1 (en) 2009-07-10 2011-01-12 Schmülling, Thomas Disruption of CKX3 and at least one other CKX gene in a plant or plant cell leads to improved traits
EP3476939A4 (en) * 2016-07-08 2019-06-05 Tak-Circulator Co., Ltd. NUCLEIC ACID INHIBITING MEX3B GENE EXPRESSION, MEX3B GENE EXPRESSION INHIBITOR, METHOD FOR INHIBITING MEX3B GENE EXPRESSION, AGENT FOR PREVENTING OR TREATING DISEASES CAUSED BY MEX3B GENE EXPRESSION
WO2018008750A1 (en) 2016-07-08 2018-01-11 ＴＡＫ－Ｃｉｒｃｕｌａｔｏｒ株式会社 Method for screening agents for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, tnf, g-csf, cxcl1, cxcl2, or cxcl5 and agent for the prevention or treatment of diseases caused by interleukin 6, interleukin 13, tnf, g-csf, cxcl1, cxcl2, or cxcl5

Also Published As

Publication number Publication date
WO2002031136A1 (en) 2002-04-18
US6395544B1 (en) 2002-05-28

Similar Documents

Publication Publication Date Title
AU2001289085A1 (en) Antisense modulation of flip-c expression
AU2001294926A1 (en) Antisense modulation of smad6 expression
AU2002309819A1 (en) Antisense modulation of PTP1B expression
AU2001277054A1 (en) Antisense modulation of lysophospholipase i expression
AU2212600A (en) Antisense modulation of g-alpha-i1 expression
AU6296099A (en) Antisense modulation of g-alpha-12 expression
AU2001289046A1 (en) Antisense modulation of her-2 expression
AU2001229447A1 (en) Antisense modulation of smad7 expression
AU2001278077A1 (en) Antisense modulation of ptp1b expression
AU2001261808A1 (en) Antisense modulation of pten expression
AU2001263171A1 (en) Antisense modulation of tert expression
AU2001239971A1 (en) Antisense modulation of parp expression
AU2001227847A1 (en) Antisense modulation of pepck-cytosolic expression
AU6115400A (en) Antisense modulation of mekk5 expression
AU2002366788A1 (en) Antisense modulation of ship-1 expression
AU2001283443A1 (en) Antisense modulation of hpk/gck-like kinase expression
AU2001288968A1 (en) Antisense modulation of btak expression
AU2002318139A1 (en) Antisense modulation of src-c expression
AU2002230869A1 (en) Antisense modulation of hepsin expression
AU2209000A (en) Antisense modulation of pepck-mitochondrial expression
AU2002357102A1 (en) Antisense modulation of cd36l1 expression
AU5486700A (en) Antisense modulation of g-alpha-s1 expression
AU2001296731A1 (en) Antisense modulation of bcas1 expression
AU2001287136A1 (en) Antisense modulation of glioma-associated oncogene-1 expression
AU2410600A (en) Antisense modulation of g-alpha-i3 expression